Quiet,
To be honest, I have them on my radar for when they list on the NYSE. The app I use does not allow me to invest in stocks ending in a 5th digit of an "F". I researched them a long time ago (I probably need to revisit) because I wanted to purchase their stock because they are cash flow positive...which is rare with cannabis stocks. Once listed on the NYSE, I will probably still buy a few just to diversify my portfolio and provided the price falls within a range I consider appropriate. With the caveat that I need to revisit my research, I get this feeling that CannTrust is really good at doing what they do, that is provide medical marijuana to Canadian medical patients. Something in my gut tells me that they know this and they plan on only thriving in this niche...for the long term...and I could be 100% wrong here...but I feel that they might be up listing to take advantage of American shareholder dollars, while really have no intentions to compete with the larger, soon to be, global cannabis companies that one might have assumed. Anyway, all my research has pointed me at the same conclusion. The Canadian companies know that in order to be truly profitable in the long term they need the American (consumer) market. Conveniently, most of the U.S. companies are a fraction of the cost per share. I am sure that there are plenty out there that are worthy of inventing in...you just have to do you DD and hope that your research doesn't fail you...while at the same time know that any investment comes with risk.
Market Data 
Markets 
AI
